| Sirolimus |
EU/1/07/171/007 |
Rapamune, Coated tablet, 1, mg, Pack: 30 |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия; Pfizer Ireland Pharmaceuticals, Ирландия |
186.23 |
37.25 |
223.48 |
4% |
7.45 |
193.68 |
38.74 |
232.42 |
16% |
25 |
218.68 |
43.74 |
262.42 |
|
НСР-8983/14.04.2016.; НСР-11279/22.12.2016 г. |
02.02.2017 |
02.02.2017 |
Неактивен |
3306 |
| Sirolimus |
EU/1/07/171/007 |
Rapamune, Coated tablet, 1, mg, Pack: 30 |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия; Pfizer Ireland Pharmaceuticals, Ирландия |
186.53 |
37.31 |
223.84 |
4% |
7.46 |
193.99 |
38.8 |
232.79 |
16% |
25 |
218.99 |
43.8 |
262.79 |
|
НСР-8983/14.04.2016. |
30.04.2016 |
30.04.2016 |
Неактивен |
3306 |
| Sirolimus |
EU/1/07/171/007 |
Rapamune, Coated tablet, 1, mg, Pack: 30 |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Deutschland GmbH, Германия; Pfizer Ireland Pharmaceuticals, Ирландия |
196.38 |
39.28 |
235.66 |
4% |
7.86 |
204.24 |
40.85 |
245.09 |
16% |
25 |
229.24 |
45.85 |
275.09 |
промяна в обстоятелствата НСР-7038/03.09.2015 |
НСР-6851/30.07.2015. |
13.08.2015 |
13.08.2015 |
Неактивен |
3306 |
| Sirolimus |
EU/1/07/171/007 |
Rapamune, Coated tablet, 1, mg, Pack: 30 |
Pfizer Limited, Обединено Кралство |
Wyeth Medica - Ireland - Ирландия; Wyeth Pharmaceutical, Великобритания |
196.42 |
39.28 |
235.7 |
4% |
7.86 |
204.28 |
40.86 |
245.14 |
16% |
25 |
229.28 |
45.86 |
275.14 |
|
НСР-4873/17.10.2014 |
03.11.2014 |
03.11.2014 |
Неактивен |
3306 |
| Sirolimus |
EU/1/07/171/007 |
Rapamune, Coated tablet, 1, mg, Pack: 30 |
Pfizer Limited, Обединено Кралство |
Wyeth Medica - Ireland - Ирландия; Wyeth Pharmaceutical, Великобритания |
199.75 |
39.95 |
239.7 |
4% |
7.99 |
207.74 |
41.55 |
249.29 |
16% |
25 |
232.74 |
46.55 |
279.29 |
|
НСР-2208/20.12.2013 |
04.01.2014 |
04.01.2014 |
Неактивен |
3306 |
| Sirolimus |
EU/1/07/171/007 |
Rapamune, Coated tablet, 1, mg, Pack: 30 |
Pfizer Limited, Обединено Кралство |
Wyeth Medica - Ireland - Ирландия; Wyeth Pharmaceutical, Великобритания |
202.29 |
40.46 |
242.75 |
4% |
8.09 |
210.38 |
42.08 |
252.46 |
16% |
25 |
235.38 |
47.08 |
282.46 |
|
КЦРР-2600/14.03.2013 |
29.03.2013 |
29.03.2013 |
Неактивен |
3306 |
| Sirolimus |
EU/1/07/171/007 |
Rapamune, Coated tablet, 1, mg, Pack: 30 |
Pfizer Limited, Обединено Кралство |
Wyeth Medica - Ireland - Ирландия; Wyeth Pharmaceuticals, Великобритания |
210.37 |
42.07 |
252.44 |
4% |
8.41 |
218.78 |
43.76 |
262.54 |
16% |
25 |
243.78 |
48.76 |
292.54 |
промяна в обстоятелствата КЦPP-1458/02.10.2012 |
КЦ-397/07.01.2009 |
30.01.2009 |
30.01.2009 |
Неактивен |
3306 |
| Lansoprazole |
№ II-0767/09.10.2007 |
Rapilasole, Gastro resistant capsule, hard, 30, mg, Pack: 28 |
Actavis Group PTC ehf., Исландия |
Liconsa, Liberacion Controlada de Substancias Actavis, SA, Spain |
8.64 |
1.73 |
10.37 |
7% |
0.6 |
9.24 |
1.85 |
11.09 |
20% |
1.73 |
10.97 |
2.19 |
13.16 |
цената се заличава КЦРР-1453/02.10.2012 |
КЦ-473/29.01.2009 |
17.02.2009 |
17.02.2009 |
Заличен |
449 |
| Lansoprazole |
№ II-0767/09.10.2007 |
Rapilasole, Gastro resistant capsule, hard, 30, mg, Pack: 14 |
Actavis Group PTC ehf., Исландия |
Liconsa, Liberacion Controlada de Substancias Actavis, SA, Spain |
3.7 |
0.74 |
4.44 |
7% |
0.26 |
3.96 |
0.79 |
4.75 |
20% |
0.74 |
4.7 |
0.94 |
5.64 |
цената се заличава КЦРР-1454/02.10.2012 |
КЦРР-880/28.06.2012 |
13.07.2012 |
13.07.2012 |
Заличен |
1278 |
| Lansoprazole |
№ II-0767/09.10.2007 |
Rapilasole, Gastro resistant capsule, hard, 30, mg, Pack: 14 |
Actavis Group PTC ehf., Исландия |
Liconsa, Liberacion Controlada de Substancias Actavis, SA, Spain |
5.01 |
1 |
6.01 |
9% |
0.45 |
5.46 |
1.09 |
6.55 |
22% |
1.1 |
6.56 |
1.31 |
7.87 |
|
КЦ-473/29.01.2009 |
17.02.2009 |
17.02.2009 |
Неактивен |
1278 |
| Reteplase |
EU/1/96/018/001 |
Rapilysin, Powder and solvent for solution for injection, 10 U (1U/ml-10 ml), -, Pack: 2 vials, 2 prefilled syringes, 2 reconstitution devices and 2 needles 19 G l |
Actavis Group PTC ehf., Исландия |
Cenexi, France; Actavis Italy S.p.A. Nerviano Plant, Италия |
1406.4 |
281.28 |
1687.68 |
4% |
10 |
1416.4 |
283.28 |
1699.68 |
16% |
25 |
1441.4 |
288.28 |
1729.68 |
промяна на обстоятелства НСР-12252/03.04.2017 г. |
НСР-2696/06.02.2014 |
26.02.2014 |
02.05.2017 |
Активен |
2509 |
| Reteplase |
EU/1/96/018/001 |
Rapilysin, Powder and solvent for solution for injection, 10 U (1U/ml-10 ml), -, Pack: 2 vials, 2 prefilled syringes, 2 reconstitution devices and 2 needles 19 G l |
Actavis Group PTC ehf., Исландия |
Cenexi, France |
1406.4 |
281.28 |
1687.68 |
4% |
10 |
1416.4 |
283.28 |
1699.68 |
16% |
25 |
1441.4 |
288.28 |
1729.68 |
|
НСР-2696/06.02.2014 |
26.02.2014 |
26.02.2014 |
Неактивен |
2509 |
| Reteplase |
EU/1/96/018/001 |
Rapilysin, Powder and solvent for solution for injection, 10 U (1U/ml-10 ml), -, Pack: 2 vials, 2 prefilled syringes, 2 reconstitution devices and 2 needles 19 G l |
Actavis Group PTC ehf., Исландия |
Cenexi, France |
1406.4 |
281.28 |
1687.68 |
4% |
10 |
1416.4 |
283.28 |
1699.68 |
16% |
25 |
1441.4 |
288.28 |
1729.68 |
|
НСР-2696/06.02.2014 |
26.02.2014 |
26.02.2014 |
Неактивен |
2509 |
| Reteplase |
EU/1/96/018/001 |
Rapilysin, Powder and solvent for solution for injection, 10 IU/10 ml, IU, Pack: 2 |
Actavis Group PTC ehf., Исландия |
Cenexi, France |
1426.03 |
285.21 |
1711.24 |
4% |
10 |
1436.03 |
287.21 |
1723.24 |
16% |
25 |
1461.03 |
292.21 |
1753.24 |
|
КЦРР-2558/14.03.2013 |
05.04.2013 |
05.04.2013 |
Неактивен |
2509 |
| Reteplase |
EU/1/96/018/001 |
Rapilysin, Powder and solvent for solution for injection, 10 IU/10 ml, IU, Pack: 2 |
Actavis Group PTC ehf., Исландия |
Cenexi, France |
1652.32 |
330.46 |
1982.78 |
4% |
10 |
1662.32 |
332.46 |
1994.78 |
16% |
25 |
1687.32 |
337.46 |
2024.78 |
|
КЦ-771/02.04.2009 |
22.04.2009 |
22.04.2009 |
Неактивен |
2509 |
| Ropinirole |
20120235 |
Raponer, Prolonged release tablet, 8, mg, Pack: 30 |
Actavis Group PTC ehf., Исландия |
Actavis Ltd., Малта |
37.57 |
7.51 |
45.08 |
4% |
1.5 |
39.07 |
7.81 |
46.88 |
16% |
6.01 |
45.08 |
9.02 |
54.1 |
|
НСР-5001/05.11.2014. |
19.11.2014 |
19.11.2014 |
Активен |
3347 |
| Ropinirole |
20120233 |
Raponer, Prolonged release tablet, 4, mg, Pack: 30 |
Actavis Group PTC ehf., Исландия |
Actavis Ltd., Малта |
18.19 |
3.64 |
21.83 |
6% |
1.09 |
19.28 |
3.86 |
23.14 |
18% |
3.27 |
22.55 |
4.51 |
27.06 |
|
НСР-5001/05.11.2014. |
19.11.2014 |
19.11.2014 |
Активен |
3346 |
| Ropinirole |
20120231 |
Raponer, Prolonged release tablet, 2, mg, Pack: 30 |
Actavis Group PTC ehf., Исландия |
Actavis Ltd., Малта |
8.88 |
1.78 |
10.66 |
7% |
0.62 |
9.5 |
1.9 |
11.4 |
20% |
1.78 |
11.28 |
2.26 |
13.54 |
|
НСР-5001/05.11.2014. |
19.11.2014 |
19.11.2014 |
Активен |
3345 |
| Ropinirole |
20120231 |
Raponer, Prolonged release tablet, 2, mg, Pack: 21 |
Actavis Group PTC ehf., Исландия |
Actavis Ltd. Malta |
7.37 |
1.47 |
8.84 |
7% |
0.52 |
7.89 |
1.58 |
9.47 |
20% |
1.47 |
9.36 |
1.87 |
11.23 |
цената е заличена с решение НСР-7351/29.10.2015 (в сила от 02.12.2015) |
НСР-5743/26.02.2015. |
12.03.2015 |
12.03.2015 |
Заличен |
3634 |
| Ropinirole |
20120233 |
Raponer, Prolonged release tablet, 4, mg, Pack: 21 |
Actavis Group PTC ehf., Исландия |
Actavis Ltd. Malta |
13.48 |
2.7 |
16.18 |
6% |
0.81 |
14.29 |
2.86 |
17.15 |
18% |
2.43 |
16.72 |
3.34 |
20.06 |
цената е заличена с решение НСР-7342/29.10.2015 (в сила от 02.12.2015) |
НСР-3816/16.06.2014 |
01.07.2014 |
01.07.2014 |
Заличен |
2961 |
| Ropinirole |
20120235 |
Raponer, Prolonged release tablet, 8, mg, Pack: 21 |
Actavis Group PTC ehf., Исландия |
Actavis Ltd. Malta |
25.45 |
5.09 |
30.54 |
6% |
1.53 |
26.98 |
5.4 |
32.38 |
18% |
4.58 |
31.56 |
6.31 |
37.87 |
цената е заличена с решение НСР-7788/28.12.2015 (в сила от 02.02.2016) |
НСР-3815/16.06.2014 |
01.07.2014 |
01.07.2014 |
Заличен |
2960 |
| Ropinirole |
20120235 |
Raponer, Prolonged release tablet, 8, mg, Pack: 21 |
Actavis Group PTC ehf., Исландия |
Actavis Ltd. Malta |
26.42 |
5.28 |
31.7 |
6% |
1.59 |
28.01 |
5.6 |
33.61 |
18% |
4.76 |
32.77 |
6.55 |
39.32 |
|
НСР-1221/23.09.2013 |
11.10.2013 |
11.10.2013 |
Неактивен |
2960 |
| Ropinirole |
20120233 |
Raponer, Prolonged release tablet, 4, mg, Pack: 21 |
Actavis Group PTC ehf., Исландия |
Actavis Ltd. Malta |
13.69 |
2.74 |
16.43 |
6% |
0.82 |
14.51 |
2.9 |
17.41 |
18% |
2.46 |
16.97 |
3.39 |
20.36 |
|
НСР-1220/23.09.2013 |
11.10.2013 |
11.10.2013 |
Неактивен |
2961 |
| Ropinirole |
20120235 |
Raponer, Prolonged release tablet, 8, mg, Pack: 21 |
Actavis Group PTC ehf., Исландия |
Actavis Ltd. Malta |
35.38 |
7.08 |
42.46 |
4% |
1.42 |
36.8 |
7.36 |
44.16 |
16% |
5.66 |
42.46 |
8.49 |
50.95 |
|
КЦРР-1816/12.12.2012 ; КЦРР-1861/15.12.2012 |
19.12.2012 |
19.12.2012 |
Неактивен |
2960 |
| Ropinirole |
20120233 |
Raponer, Prolonged release tablet, 4, mg, Pack: 21 |
Actavis Group PTC ehf., Исландия |
Actavis Ltd. Malta |
18.38 |
3.68 |
22.06 |
6% |
1.1 |
19.48 |
3.9 |
23.38 |
18% |
3.31 |
22.79 |
4.56 |
27.35 |
|
КЦРР-1816/12.12.2012 ; КЦРР-1861/15.12.2012 |
19.12.2012 |
19.12.2012 |
Неактивен |
2961 |